Known targets — ChEMBL curated mechanism
ADRA2AADRA2BADRA2CADRB2AGTR1AVPR1AAVPR1BAVPR2BDKRB2CALCRCHRNA3CHRNB4ESR1ESR2GHSRGNRHRGSC1HSPA8MALT1MC1RMC4RNOS1NOS2NOS3OPRK1OXTRRAMP1RAMP2RAMP3SCN5ASSTR1SSTR2SSTR3SSTR4SSTR5dacAdacBdacCfolPftsImrcAmrcBmrdArplArplBrplCrplDrplErplFrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmFrpmGrpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO
The experimentally established mechanism targets of Acetic Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FFAR3 | O14843 | 1/20 | 0.32 |
| ▸ | LCK | P06239 | 1/20 | 0.32 |
| ▸ | FYN | P06241 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Acetic Acid SCHEMBL27658185 | 0.74 | FFAR3 (0.33) | FFAR3LCKFYN | |
| Acetic Acid SCHEMBL11245661 | 0.73 | HCAR2 (0.32) | FFAR3LCKFYN | |
| Acetic Acid SCHEMBL4111573 | 0.70 | HCAR2 (0.32) | — | |
| SCHEMBL1238342 | 0.64 | — | — | |
| Acetic Acid SCHEMBL28989996 | 0.61 | — | — | |
| Acetic Acid SCHEMBL28087577 | 0.57 | — | — | |
| Acetic Acid SCHEMBL5191048 | 0.57 | — | — | |
| Acetic Acid SCHEMBL8742314 | 0.56 | FFAR3 (1.00) | FFAR3LCKFYN | |
| Acetic Acid SCHEMBL1330415 | 0.56 | — | — | |
| Acetic Acid SCHEMBL1331719 | 0.56 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 49 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-107805225-B | Preparation method of 5-mercapto tetrazole acetic acid and sodium salt thereof | 九江中星医药化工有限公司 | 2020-06-26 | — | — | CN | claimed |
| CN-107805225-A | The preparation method of 5 mercapto tetrazole acetic acid and its sodium salt | 九江中星医药化工有限公司 | 2018-03-16 | — | — | CN | claimed |
| EP-2112949-A1 | PRODUCTION OF BIOFUEL AND PROTEIN FROM A RAW MATERIAL | UPFRONT CHROMATOGRAPHY A/S (DK) | 2009-11-04 | — | — | EP | claimed |
| WO-2008086811-A1 | PRODUCTION OF BIOFUEL AND PROTEIN FROM A RAW MATERIAL | UPFRONT CHROMATOGRAPHY A/S (DK) | 2008-07-24 | — | — | WO | claimed |
| US-6919436-B2 | Isolation of proteins | UPFRONT CHROMATOGRAPHY A/S (DK) | 2005-07-19 | — | — | US | claimed |
| EP-1386660-A1 | Isolation of proteins | UPFRONT CHROMATOGRAPHY A/S (DK) | 2004-02-04 | — | — | EP | claimed |
| US-20030187227-A1 | Isolation of immunoglobulins | UPFRONT CHROMATOGRAPHY A/S | 2003-10-02 | — | — | US | claimed |
| EP-0921855-A1 | ISOLATION OF IMMUNOGLOBULINS | UPFRONT CHROMATOGRAPHY A/S (DK) | 1999-06-16 | — | — | EP | claimed |
| WO-1998008603-A1 | ISOLATION OF IMMUNOGLOBULINS | UPFRONT CHROMATOGRAPHY A/S (DK) | 1998-03-05 | — | — | WO | claimed |
| US-12516143-B2 | Polystyrene-based polyampholyte having upper critical solution temperature, and application for same | TOSOH FINECHEM CORPORATION (JP) | 2026-01-06 | — | — | US | disclosed |
| EP-3666753-B1 | HIGH-PURITY AMPHIPATHIC ARYLSULFONIC ACID AMINE SALT VINYL MONOMER AND COPOLYMER THEREOF | TOSOH FINECHEM CORP (JP) | 2024-09-11 | — | — | EP | disclosed |
| WO-2023171597-A1 | HIGH-PURITY 4-(2-BROMOETHYL)BENZENESULFONIC ACID, HIGH-PURITY STYRENESULFONIC ACIDS DERIVED THEREFROM AND POLYMERS THEREOF, AND METHODS FOR PRODUCING SAME | 東ソー・ファインケム株式会社 | 2023-09-14 | — | — | WO | disclosed |
| US-11459410-B2 | High-purity amphipathic arylsulfonic acid amine salt vinyl monomer and copolymer thereof | TOSOH FINECHEM CORPORATION (JP) | 2022-10-04 | — | — | US | disclosed |
| US-20220073661-A1 | NOVEL POLYSTYRENE-BASED POLYAMPHOLYTE HAVING UPPER CRITICAL SOLUTION TEMPERATURE, AND APPLICATION FOR SAME | TOSOH FINECHEM CORPORATION (JP) | 2022-03-10 | — | — | US | disclosed |
| WO-2014064132-A1 | SEPARATION PROCESSES FOR SOY PROTEIN | UPFRONT CHROMATOGRAPHY A/S (DK) | 2014-05-01 | — | — | WO | disclosed |
| US-20100120107-A1 | combined production of a biofuel and the purification of a protein product using an expanded bed adsorption process; cost efficient use of protein by-product; generate bioethanol, hydrogen, biodiesel, biobutanol, biopropanol; high energy yield | UPFRONT CHROMATOGRAPHY A/S | 2010-05-13 | — | — | US | disclosed |
| EP-2112949-A1 | PRODUCTION OF BIOFUEL AND PROTEIN FROM A RAW MATERIAL | UPFRONT CHROMATOGRAPHY A/S (DK) | 2009-11-04 | — | — | EP | disclosed |
| WO-2008086811-A1 | PRODUCTION OF BIOFUEL AND PROTEIN FROM A RAW MATERIAL | UPFRONT CHROMATOGRAPHY A/S (DK) | 2008-07-24 | — | — | WO | disclosed |
| EP-0921855-A1 | ISOLATION OF IMMUNOGLOBULINS | UPFRONT CHROMATOGRAPHY A/S (DK) | 1999-06-16 | — | — | EP | disclosed |
| WO-1998008603-A1 | ISOLATION OF IMMUNOGLOBULINS | UPFRONT CHROMATOGRAPHY A/S (DK) | 1998-03-05 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11459410-B2 | High-purity amphipathic arylsulfonic acid amine salt vinyl monomer and copolymer thereof | SLC7A1, ARSA, STS | FFAR3 1106/4885LCK 1509/4885FYN 601/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.